Edoceo Devices
Emerging med‑tech and biotech company developing portable biosensor platforms for rapid, point‑of‑need detection of viral and bacterial pathogens. Technology licensed from a US university research team; product efforts include a CE‑approved saliva antigen test for respiratory virus antigens, and prototype portable devices for virulent bacterial detection and configurable viral RNA detection. Activities described include device and consumable design, software for data collection, manufacturing scale‑up, distribution in CE markets, and regulatory filings toward US market access.
Industries
Nr. of Employees
small (1-50)
Edoceo Devices
Boulder, Colorado, United States, North America
Products
CE‑certified rapid saliva antigen test (saliva antigen lateral‑flow kit)
Saliva‑based lateral‑flow antigen test for rapid on‑site detection of respiratory virus antigens with a visual readout and a sample collection method based on an absorbent oral swab; reported CE certification for sale in countries accepting the CE mark.
Portable virulent bacterial detection device (prototype)
Prototype handheld device concept designed to detect the presence of multiple bacterial pathogens in a virulent state with a short turnaround time; intended for aquaculture, veterinary and food‑processing monitoring.
Portable viral biosensing platform (prototype)
Configurable portable platform intended to detect viral targets via genetic recognition and amplification, designed for point‑of‑need use and transferable to multiple viral targets.
A-Detect TM Rapid Saliva Antigen Test
A rapid saliva antigen test kit that provides fast, simple, and affordable results in 15 minutes using a saliva sample collected beneath the tongue.
Edoceo - A-Detect™ The Rapid, Simple Saliva Antigen Test
A simple, rapid, and affordable antigen test that provides results in 17 minutes or less by testing saliva for viral antigens. Approved for the European market with CE marking and planned US FDA approval.
Edoceo - V-Detect™ A Portable Virus Biosensing Device
A rapid-testing platform leveraging advanced biosensing technology for detecting various viral threats with accurate antigen test results based on direct RNA amplification. Portable, fast, simple readout, and affordable for multiple markets including schools, offices, and factories.
CE‑certified rapid saliva antigen test (saliva antigen lateral‑flow kit)
Saliva‑based lateral‑flow antigen test for rapid on‑site detection of respiratory virus antigens with a visual readout and a sample collection method based on an absorbent oral swab; reported CE certification for sale in countries accepting the CE mark.
Portable virulent bacterial detection device (prototype)
Prototype handheld device concept designed to detect the presence of multiple bacterial pathogens in a virulent state with a short turnaround time; intended for aquaculture, veterinary and food‑processing monitoring.
Portable viral biosensing platform (prototype)
Configurable portable platform intended to detect viral targets via genetic recognition and amplification, designed for point‑of‑need use and transferable to multiple viral targets.
A-Detect TM Rapid Saliva Antigen Test
A rapid saliva antigen test kit that provides fast, simple, and affordable results in 15 minutes using a saliva sample collected beneath the tongue.
Edoceo - A-Detect™ The Rapid, Simple Saliva Antigen Test
A simple, rapid, and affordable antigen test that provides results in 17 minutes or less by testing saliva for viral antigens. Approved for the European market with CE marking and planned US FDA approval.
Edoceo - V-Detect™ A Portable Virus Biosensing Device
A rapid-testing platform leveraging advanced biosensing technology for detecting various viral threats with accurate antigen test results based on direct RNA amplification. Portable, fast, simple readout, and affordable for multiple markets including schools, offices, and factories.
Services
Distribution and sales through regional agents for a CE‑certified saliva antigen test; commercial deployment in countries accepting CE marking.
License management and collaborative engineering with university research teams to advance prototype diagnostics toward commercialization.
Distribution and sales through regional agents for a CE‑certified saliva antigen test; commercial deployment in countries accepting CE marking.
License management and collaborative engineering with university research teams to advance prototype diagnostics toward commercialization.
Expertise Areas
- Point‑of‑need diagnostics
- Biosensor engineering
- Microfluidics and capillary flow assays
- Lateral‑flow molecular diagnostics
Key Technologies
- Lateral‑flow assays (paper‑based)
- Direct RNA amplification
- Antigen detection in saliva
- Microfluidics (passive/active mixing, passive pumping)
News & Updates
Press release announcing a worldwide strategic and preferred distribution agreement for a saliva‑based rapid antigen test with CE certification; reported on December 31, 2020.
Press release (July 16, 2020) describing a licensed viral RNA testing platform from a university research team to support development of a portable and accurate SARS‑CoV‑2 test and broader diagnostic platform.
Press release announcing a worldwide strategic and preferred distribution agreement for a saliva‑based rapid antigen test with CE certification; reported on December 31, 2020.
Press release (July 16, 2020) describing a licensed viral RNA testing platform from a university research team to support development of a portable and accurate SARS‑CoV‑2 test and broader diagnostic platform.